FIELD: bioengineering.
SUBSTANCE: invention relates to the new compounds of the common formula where each of m and n independently discloses 0 or 1; R1 and R2, together with a carbon atom whereto these are connected to make a heterocyclic ring containing one or two heteroatoms selected from oxygen, sulphur, -S(O)- and -S(O)2-; R3 stands for -CHF2, -CF3, -OCHF2, -OCF3, -SCHF2 or -SCF3; or their pharmaceutically acceptable salts, hydrates or solvates. Besides, it relates to pharmaceutical compositions based thereon and to the treatment of inflammation.
EFFECT: active inhibition of PDF4, efficient treatment of inflammation.
28 cl, 1 tbl, 15 ex
Title | Year | Author | Number |
---|---|---|---|
NEW PHOSPHODIESTERASE INHIBITORS | 2008 |
|
RU2495043C2 |
METHODS OF PRODUCING 1, 3-BENZODIOXOLE HETEROCYCLIC COMPOUNDS | 2015 |
|
RU2697251C2 |
METHODS OF PREPARING 1,3-BENZODIOXOL HETEROCYCLIC COMPOUNDS | 2018 |
|
RU2814175C2 |
METHOD FOR PRODUCING HETEROCYCLIC COMPOUNDS OF 1,3-BENZODIOXOL | 2016 |
|
RU2761337C2 |
1-PHENYL-2-PYRIDINYLALKYL ALCOHOLS DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS | 2012 |
|
RU2626956C2 |
SUBSTITUTED METHYLPHENYL KETONES SUITABLE FOR USE AS PDE4 INHIBITORS | 2007 |
|
RU2493149C2 |
NOVEL BENZODIOXOLS | 2003 |
|
RU2304580C2 |
1-PHENYL-2-PYRIDINYL ALKYL ALCOHOL DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS | 2013 |
|
RU2655170C2 |
SUBSTITUTED CHROMANS | 2015 |
|
RU2718060C2 |
SUBSTITUTED PYRAZOLES | 2001 |
|
RU2286343C2 |
Authors
Dates
2016-05-10—Published
2011-06-24—Filed